The role of macrolides in noncystic fibrosis bronchiectasis

Pulmonary Medicine

Volumn , Issue , 2011, Pages

  Figueiredo, Bruna De Campos Guimarães E ^a   Ibiapina, Cássio Da Cunha ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; BRONCHIECTASIS; BRONCHIOLITIS; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG MECHANISM; EVIDENCE BASED PRACTICE; HUMAN; IMMUNOMODULATION; LOW DRUG DOSE; LUNG FIBROSIS; LUNG FUNCTION; MEDLINE; PRIORITY JOURNAL; REVIEW; SPUTUM;

EID: 84876240621     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2011/751982     Document Type: Review

References (33)

1. Washington J. A., Wilson W. R., Erythromycin. A microbial and clinical perspective after 30years of clinical use Mayo Clinic Proceedings 1985 60 3 189 203 (Pubitemid 15139126)
2. Zuckerman J. M., Macrolides and ketolides: azithromycin, clarithromycin, telithromycin Infectious Disease Clinics of North America 2004 18 3 621 649 (Pubitemid 39089098)
3. Lopez-Boado Y. S., Rubin B. K., Macrolides as immunomodulatory medications for the therapy of chronic lung diseases Current Opinion in Pharmacology 2008 8 3 286 291
4. Healy D. P., Macrolide immunomodulation of chronic respiratory diseases Current Infectious Disease Reports 2007 9 1 7 13 (Pubitemid 46242407)
5. Florescu D. F., Murphy P. J., Kalil A. C., Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis Pulmonary Pharmacology Therapeutics 2009 22 6 467 472
6. Whitman M. S., Tunkel A. R., Azithromycin and clarithromycin: overview and comparison with erythromycin Infection Control and Hospital Epidemiology 1992 13 6 357 368
7. Itkin I. H., Menzel M. L., The use of macrolide antibiotic substances in the treatment of asthma Journal of Allergy 1970 45 3 146 162
8. Shinkai M., Rubin B. K., Macrolides and airway inflammation in children Paediatric Respiratory Reviews 2005 6 3 227 235 (Pubitemid 41258653)
9. Kudoh S., Clinical efficacy of erythromycin treatment for diffuse panbronchiolitis multicenter retrospective study The 1988 Annual Report of Diffuse Parenchymal Lung Disease Research Committee 1989 Tokyo, Japan Japanese Ministry of Health and Welfare 157 159
10. Yamamoto M., Erythromycin treatment for diffuse panbronchiolitis; results of multicenter double-blind prospective study The 1990 Annual Report of Diffuse Parenchymal Lung Disease Research Committee 1990 Tokyo, Japan Japanese Ministry of Health and Welfare 18 21
11. Kadota J., Mukae H., Ishii H., Nagata T., Kaida H., Tomono K., Kohno S., Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis Respiratory Medicine 2003 97 7 844 850 (Pubitemid 36763898)
12. Ichikawa Y., Hotta M., Sumita S., Fujimoto K., Oizumi K., Reversible airway lesions in diffuse panbronchiolitis: detection by high- resolution computed tomography Chest 1995 107 1 120 125
13. Fujii T., Kadota J. I., Kawakami K., Iida K., Shirai R., Kaseda M., Kawamoto S., Kohno S., Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection Thorax 1995 50 12 1246 1252
14. Shirai T., Sato A., Chida K., Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity Internal Medicine 1995 34 6 469 474
15. Kudoh S., Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases The American Journal of Medicine 2004 117 supplement 9 12S 19S
16. Kudoh S., Azuma A., Yamamoto M., Izumi T., Ando M., Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin American Journal of Respiratory and Critical Care Medicine 1998 157 6 1829 1832
17. Jaffe A., Francis J., Rosenthal M., Bush A., Long-term azithromycin may improve lung function in children with cystic fibrosis The Lancet 1998 351 9100 420 (Pubitemid 28064175)
18. Yousef A. A., Jaffe A., The role of azithromycin in patients with cystic fibrosis Paediatric Respiratory Reviews 2010 11 2 108 114
19. Richeldi L., Ferrara G., Fabbri L. M., Lasserson T. J., Gibson P. G., Macrolides for chronic asthma Cochrane Database of Systematic Rewies 2005 4, article CD002997
20. Gencay M., Rudiger J. J., Tamm M., Solér M., Perruchoud A. P., Roth M., Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma American Journal of Respiratory and Critical Care Medicine 2001 163 5 1097 1100 (Pubitemid 32378443)
21. Amayasu H., Yoshida S., Ebana S., Yamamoto Y., Nishikawa T., Shoji T., Nakagawa H., Hasegawa H., Nakabayashi M., Ishizaki Y., Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma Annals of Allergy, Asthma Immunology 2000 84 6 594 598 (Pubitemid 30418859)
22. Pasteur M. C., Bilton D., Hill A. T., British thoracic society guideline for non-CF bronchiectasis Thorax 2010 65 supplement 1 i1 i58
23. Koh Y. Y., Lee M. H., Sun Y. H., Sung K. W., Chae J. H., Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study European Respiratory Journal 1997 10 5 994 999 (Pubitemid 27201800)
24. Tsang K. W. T., Ho P. I., Chan K. N., Ip M. S. M., Lam W. K., Ho C. S., Yuen K. Y., Ooi G. C., Amitani R., Tanaka E., A pilot study of low-dose erythromycin in bronchiectasis European Respiratory Journal 1999 13 2 361 364 (Pubitemid 29086834)
25. Davies G., Wilson R., Prophylactic antibiotic treatment of bronchiectasis with azithromycin Thorax 2004 59 6 540 541 (Pubitemid 38797534)
26. Cymbala A. A., Edmonds L. C., Bauer M. A., Jederlinic P. J., May J. J., Victory J. M., Amsden G. W., The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis Treatments in Respiratory Medicine 2005 4 2 117 122 (Pubitemid 40613959)
27. Yalcin E., Kiper N., Ozcelik U., Effects of clarithromycin on inflammatory parameters and clinical conditions in children with bronchiectasis Journal of Clinical Pharmacy and Therapeutics 2006 31 1 49 55
28. Anwar G. A., Bourke S. C., Afolabi G., Middleton P., Ward C., Rutherford R. M., Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis Respiratory Medicine 2008 102 10 1494 1496
29. Serisier D. J., Martin M. L., Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations Respiratory Medicine 2011 105 6 946 949
30. Kourlas H., Anti-inflammatory properties of macrolide antibiotics Journal of Pharmacy Practice 2006 19 5 326 329 (Pubitemid 46718551)
31. Shinkai M., Henke M. O., Rubin B. K., Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action Pharmacology and Therapeutics 2008 117 3 393 405
32. Culi O., Erakovi V., Parnham M. J., Anti-inflammatory effects of macrolide antibiotics European Journal of Pharmacology 2001 429 1-3 209 229 (Pubitemid 33043997)
33. King P., Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs 2007 67 7 965 974 (Pubitemid 46744473)